Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients: Evidence for a central role of adipose tissue

Diabetes Care

Volumn 20, Issue 12, 1997, Pages 1863-1869

  Abbasi, Fahim ^a   Kamath, Vinaya ^a   Rizvi, Ali A ^a   Carantoni, Marcello ^a   Chen, Y D I ^a   Reaven, Gerald M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Shaman Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; METFORMIN; PLACEBO; SULFONYLUREA DERIVATIVE;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; MALE; METABOLIC CLEARANCE RATE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME;

EID: 0030827537     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.12.1863     Document Type: Article

References (28)

1. Reaven GM, Johnston P, Hollenbeck CB, Skowronski R, Zhang J-C, Goldfine ID, Chen YD-I: Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control. J Clin Endocrinol Metab 74:1020-1026, 1992
2. Jeppesen J, Zhou M-Y, Chen YD-I, Reaven GM: Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM. Diabetes Care 17:1093-1099, 1994
3. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE: Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333:550-554, 1995
4. Cusi K, Consoli A, DeFronzo R: Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4059-4067, 1996
5. Chen YD-I, Jeng C, Hollenbeck C, Wu M, Reaven G: Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes. J Clin Invest 82:21-25, 1988
6. Jeng C-Y, Sheu WH-H, Fuh MM-T, Chen YD-I, Reaven GM: Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes 43:1440-1444, 1994
7. Hother-Nielsen O, Beck-Nielsen H: Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus. Acta Endocrinol 124:637-645, 1991
8. Del Prato S, Marchetto S, Pipitone A, Zanon M, de Kreutzenberg SV, Tiengo A: Metformin and free fatty acid metabolism. Diabetes Metab Rev 11:S33-S41, 1995
9. Fraze E, Donner CC, Swislocki ALM, Chiou Y-AM, Chen YD-I, Reaven GM: Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 61:807-811, 1985
10. Reaven GM, Hollenbeck CB, Jeng C-Y, Wu MS, Chen YD-I: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37:1020-1024, 1988
11. Foley JE: Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15:773-781, 1992
12. Randle PJ, Garland PB, Hales CN, Newsholm EA: The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
13. Kadish AH, Little RL, Sterberg JC: A new rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
14. Hales CN, Randle PJ: Immunoassay of insulin with insulin antibody precipitate. Biochem J 88:137-139, 1968
15. Noma A, Okabe H, Kita M: A new calorimetric micro-determination of free fatty acids in serum. Clin Chim Acta 43:317-320, 1973
16. Trinder P: Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 22:158-161, 1969
17. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430, 1959
18. Swislocki ALM, Chen Y-DI, Golay A, Chang MO, Reaven GM: Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 30:622-626, 1987
19. Prager R, Schernthaner G, Graf H: Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus. Diabet Med 5:315-319, 1988
20. Nosadini R, Avogaro A, Trevisan R, Valerio A, Tessari P, Duner E, Tiengo A, Velussi M, Del Prato S, DeKreuzenberg S, Muggeo M, Crepaldi G: Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. Diabetes Care 10:62-67, 1987
21. Groop L, Widen E, Franssila-Kallunki A, Ekstrand A, Saloranta C, Schalin C, Eriksson J: Different effects of insulin and oral anti-diabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus. Diabetoiogia 32: 599-605, 1989
22. Wu MS, Johnston P, Sheu WH-H, Hollenbeck CB, Jeng C-Y, Goldfine ID, Chen Y-DI, Reaven GM: Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13:1-8, 1990
23. Hollenbeck CB, Johnston P, Varasteh BB, Chen Y-DI, Reaven GM: Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridemia and non-insulin dependent diabetes by glucose tolerance test criteria. Diabete Metab 17:483-489, 1991
24. Jackson RA, Hawa MI, Jaspan JB, Sim BM, Disilvio L, Featherbe D, Kurtz AB: Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes 36:632-640, 1987
25. DeFronzo RA, Barzilai N, Simonson DC: Mechanism of metformin action in obese and lean non insulin-dependent diabetic subjects. J Clin Endocrinol Metab 73:1294-1301, 1991
26. Purrello F, Gullo D, Brunetti A, Buscema M, Italia S, Goldfine ID, Vigneri R: Direct effect of biguanides on glucose utilization in vivo. Metabolism 36:774-776, 1987
27. Fery F, Plat M, Baleriaux M, Balasse EO: Inhibition of lipolysis stimulates whole body glucose production and disposal in normal postabsorptive subjects. J Clin Endocrinol Metab 82:825-830, 1997
28. Reaven GM: The fourth Musketeer: from Alexandre Dumas to Claude Bernard. Diabetologia 38:3-13, 1995